Scivision Biotech Inc. operates as a biotechnological company focused on the research, development, and commercialization of innovative healthcare solutions. The company primarily specializes in the production and distribution of advanced enzyme and protein-based products, catering to a wide range of sectors within the medical and environmental fields. Notably, Scivision Biotech is involved in producing hyaluronic acid-related products, which are extensively used in medical aesthetics, such as dermal fillers, as well as in the pharmaceutical industry for eye surgeries and osteoarthritis treatments. The company plays a crucial role in enhancing healthcare solutions through its cutting-edge biotechnological applications. Based in Taiwan, Scivision Biotech extends its market presence across Asia and globally, contributing significantly to the advancement of medical treatments and therapeutic applications. Its innovations support the biotechnology industry's growth and underscore the importance of biotechnology in modern healthcare solutions. Through strategic partnerships and a strong emphasis on research, Scivision Biotech continues to impact the biotechnological landscape significantly.